NCT02008864View on ClinicalTrials.gov

Evaluating the Effect of Senna in Uremic Pruritus

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2012

Conditions
End Stage Renal DiseasePruritus
Interventions
DRUG

Senna

(7.5 mg of sennosoides A and B) Senna tablet/ 2 times per day

DRUG

Placebo

Placebo tablet/ 2 times per day

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT02008864 - Evaluating the Effect of Senna in Uremic Pruritus | Biotech Hunter | Biotech Hunter